Selected research
Industry Research
EPA & DHA (Omega 3) Ingredients Industry Research Report 2026
Market perspective
The global EPA & DHA (Omega 3) Ingredients market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for EPA & DHA (Omega 3) Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for EPA & DHA (Omega 3) Ingredients is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for EPA & DHA (Omega 3) Ingredients is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of EPA & DHA (Omega 3) Ingredients include Lonza, Omega Protein, Martek, GC Rieber Oils, DSM, Croda, BASF, Axellus and Algae EPAX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global EPA & DHA (Omega 3) Ingredients market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
EPA & DHA (Omega 3) Ingredients Market by Company
Lonza
Omega Protein
Martek
GC Rieber Oils
DSM
Croda
BASF
Axellus
Algae EPAX
Aker BioMarine
EPA & DHA (Omega 3) Ingredients Segment by Type
Low Concentrates
Anchovy/Sardine
High Concentrates
Salmon Oil
Algae Oil
Cod Liver Oil
Medium Concentrates
EPA & DHA (Omega 3) Ingredients Segment by Application
Infant Formulas
Pharmaceuticals
Dietary Supplements
Functional Foods
Pet & Animal Feed
EPA & DHA (Omega 3) Ingredients Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA & DHA (Omega 3) Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EPA & DHA (Omega 3) Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA & DHA (Omega 3) Ingredients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of EPA & DHA (Omega 3) Ingredients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of EPA & DHA (Omega 3) Ingredients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of EPA & DHA (Omega 3) Ingredients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Low Concentrates
- Anchovy/Sardine
- High Concentrates
- Salmon Oil
- Algae Oil
- Cod Liver Oil
- Medium Concentrates
Applications
- Infant Formulas
- Pharmaceuticals
- Dietary Supplements
- Functional Foods
- Pet & Animal Feed
Companies covered
- Lonza
- Omega Protein
- Martek
- GC Rieber Oils
- DSM
- Croda
- BASF
- Axellus
- Algae EPAX
- Aker BioMarine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global EPA & DHA (Omega 3) Ingredients Market Size (2021-2032)
- 2.2.2 Global EPA & DHA (Omega 3) Ingredients Sales (2021-2032)
- 2.2.3 Global EPA & DHA (Omega 3) Ingredients Market Average Price (2021-2032)
- 2.3 EPA & DHA (Omega 3) Ingredients by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Low Concentrates
- 2.3.3 Anchovy/Sardine
- 2.3.4 High Concentrates
- 2.3.5 Salmon Oil
- 2.3.6 Algae Oil
- 2.3.7 Cod Liver Oil
- 2.3.8 Medium Concentrates
- 2.4 EPA & DHA (Omega 3) Ingredients by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Infant Formulas
- 2.4.3 Pharmaceuticals
- 2.4.4 Dietary Supplements
- 2.4.5 Functional Foods
- 2.4.6 Pet & Animal Feed
3 Market Competitive Landscape by Manufacturers
- 3.1 Global EPA & DHA (Omega 3) Ingredients Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global EPA & DHA (Omega 3) Ingredients Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global EPA & DHA (Omega 3) Ingredients Revenue of Manufacturers (2021-2026)
- 3.4 Global EPA & DHA (Omega 3) Ingredients Average Price by Manufacturers (2021-2026)
- 3.5 Global EPA & DHA (Omega 3) Ingredients Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of EPA & DHA (Omega 3) Ingredients, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of EPA & DHA (Omega 3) Ingredients, Product Type & Application
- 3.8 Global Manufacturers of EPA & DHA (Omega 3) Ingredients, Established Date
- 3.9 Global EPA & DHA (Omega 3) Ingredients Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Lonza
- 4.1.1 Lonza Company Information
- 4.1.2 Lonza Business Overview
- 4.1.3 Lonza EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Lonza EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.1.5 Lonza Recent Developments
- 4.2 Omega Protein
- 4.2.1 Omega Protein Company Information
- 4.2.2 Omega Protein Business Overview
- 4.2.3 Omega Protein EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Omega Protein EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.2.5 Omega Protein Recent Developments
- 4.3 Martek
- 4.3.1 Martek Company Information
- 4.3.2 Martek Business Overview
- 4.3.3 Martek EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Martek EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.3.5 Martek Recent Developments
- 4.4 GC Rieber Oils
- 4.4.1 GC Rieber Oils Company Information
- 4.4.2 GC Rieber Oils Business Overview
- 4.4.3 GC Rieber Oils EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GC Rieber Oils EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.4.5 GC Rieber Oils Recent Developments
- 4.5 DSM
- 4.5.1 DSM Company Information
- 4.5.2 DSM Business Overview
- 4.5.3 DSM EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 DSM EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.5.5 DSM Recent Developments
- 4.6 Croda
- 4.6.1 Croda Company Information
- 4.6.2 Croda Business Overview
- 4.6.3 Croda EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Croda EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.6.5 Croda Recent Developments
- 4.7 BASF
- 4.7.1 BASF Company Information
- 4.7.2 BASF Business Overview
- 4.7.3 BASF EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 BASF EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.7.5 BASF Recent Developments
- 4.8 Axellus
- 4.8.1 Axellus Company Information
- 4.8.2 Axellus Business Overview
- 4.8.3 Axellus EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Axellus EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.8.5 Axellus Recent Developments
- 4.9 Algae EPAX
- 4.9.1 Algae EPAX Company Information
- 4.9.2 Algae EPAX Business Overview
- 4.9.3 Algae EPAX EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Algae EPAX EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.9.5 Algae EPAX Recent Developments
- 4.10 Aker BioMarine
- 4.10.1 Aker BioMarine Company Information
- 4.10.2 Aker BioMarine Business Overview
- 4.10.3 Aker BioMarine EPA & DHA (Omega 3) Ingredients Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Aker BioMarine EPA & DHA (Omega 3) Ingredients Product Portfolio
- 4.10.5 Aker BioMarine Recent Developments
5 Global EPA & DHA (Omega 3) Ingredients Market Scenario by Region
- 5.1 Global EPA & DHA (Omega 3) Ingredients Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2021-2032
- 5.2.1 Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2021-2026
- 5.2.2 Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2027-2032
- 5.3 Global EPA & DHA (Omega 3) Ingredients Revenue by Region: 2021-2032
- 5.3.1 Global EPA & DHA (Omega 3) Ingredients Revenue by Region: 2021-2026
- 5.3.2 Global EPA & DHA (Omega 3) Ingredients Revenue by Region: 2027-2032
- 5.4 North America EPA & DHA (Omega 3) Ingredients Market Facts & Figures by Country
- 5.4.1 North America EPA & DHA (Omega 3) Ingredients Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
- 5.4.3 North America EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe EPA & DHA (Omega 3) Ingredients Market Facts & Figures by Country
- 5.5.1 Europe EPA & DHA (Omega 3) Ingredients Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
- 5.5.3 Europe EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific EPA & DHA (Omega 3) Ingredients Market Facts & Figures by Country
- 5.6.1 Asia Pacific EPA & DHA (Omega 3) Ingredients Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
- 5.6.3 Asia Pacific EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America EPA & DHA (Omega 3) Ingredients Market Facts & Figures by Country
- 5.7.1 South America EPA & DHA (Omega 3) Ingredients Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
- 5.7.3 South America EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa EPA & DHA (Omega 3) Ingredients Market Facts & Figures by Country
- 5.8.1 Middle East and Africa EPA & DHA (Omega 3) Ingredients Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa EPA & DHA (Omega 3) Ingredients Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa EPA & DHA (Omega 3) Ingredients Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2032)
- 6.1.1 Global EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Type (2021-2032)
- 6.2 Global EPA & DHA (Omega 3) Ingredients Revenue by Type (2021-2032)
- 6.2.1 Global EPA & DHA (Omega 3) Ingredients Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Type (2021-2032)
- 6.3 Global EPA & DHA (Omega 3) Ingredients Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2032)
- 7.1.1 Global EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global EPA & DHA (Omega 3) Ingredients Sales Market Share by Application (2021-2032)
- 7.2 Global EPA & DHA (Omega 3) Ingredients Revenue by Application (2021-2032)
- 7.2.1 Global EPA & DHA (Omega 3) Ingredients Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global EPA & DHA (Omega 3) Ingredients Revenue Market Share by Application (2021-2032)
- 7.3 Global EPA & DHA (Omega 3) Ingredients Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 EPA & DHA (Omega 3) Ingredients Value Chain Analysis
- 8.1.1 EPA & DHA (Omega 3) Ingredients Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 EPA & DHA (Omega 3) Ingredients Production Mode & Process
- 8.2 EPA & DHA (Omega 3) Ingredients Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 EPA & DHA (Omega 3) Ingredients Distributors
- 8.2.3 EPA & DHA (Omega 3) Ingredients Customers
9 Global EPA & DHA (Omega 3) Ingredients Analyzing Market Dynamics
- 9.1 EPA & DHA (Omega 3) Ingredients Industry Trends
- 9.2 EPA & DHA (Omega 3) Ingredients Industry Drivers
- 9.3 EPA & DHA (Omega 3) Ingredients Industry Opportunities and Challenges
- 9.4 EPA & DHA (Omega 3) Ingredients Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst